Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-28.87%
operating margin TTM
-25.07%
revenue TTM
28.44 Million
revenue per share TTM
0.29$
valuation ratios | |
|---|---|
| pe ratio | -15.81 |
| peg ratio | -0.49 |
| price to book ratio | 10.46 |
| price to sales ratio | 4.58 |
| enterprise value multiple | -23.16 |
| price fair value | 10.46 |
profitability ratios | |
|---|---|
| gross profit margin | 90.97% |
| operating profit margin | -25.07% |
| pretax profit margin | -29.02% |
| net profit margin | -28.87% |
| return on assets | -29.73% |
| return on equity | -65.73% |
| return on capital employed | -36.74% |
liquidity ratio | |
|---|---|
| current ratio | 2.75 |
| quick ratio | 2.33 |
| cash ratio | 1.05 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 484.96 |
| operating cycle | 558.55 |
| days of payables outstanding | 175.08 |
| cash conversion cycle | 383.47 |
| receivables turnover | 4.96 |
| payables turnover | 2.08 |
| inventory turnover | 0.75 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.01 |
| debt equity ratio | 0.02 |
| long term debt to capitalization | 0.01 |
| total debt to capitalization | 0.02 |
| interest coverage | -3.92 |
| cash flow to debt ratio | -27.42 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.49 |
| cash per share | 0.77 |
| operating cash flow per share | -0.48 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -27.42 |
| short term coverage ratios | -80.27 |
| capital expenditure coverage ratio | -15,336,544.20 |
Frequently Asked Questions
When was the last time Avadel Pharmaceuticals plc (NASDAQ:AVDL) reported earnings?
Avadel Pharmaceuticals plc (AVDL) published its most recent earnings results on 12-11-2024.
What is Avadel Pharmaceuticals plc's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Avadel Pharmaceuticals plc (NASDAQ:AVDL)'s trailing twelve months ROE is -65.73%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Avadel Pharmaceuticals plc (AVDL) currently has a ROA of -29.73%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did AVDL's net profit margin stand at?
AVDL reported a profit margin of -28.87% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is AVDL's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.75 in the most recent quarter. The quick ratio stood at 2.33, with a Debt/Eq ratio of 0.02.